Pump priming practices and anticoagulation in cardiac surgery: Results from the global cardiopulmonary bypass survey

Anesthesia and Analgesia

Volumn 125, Issue 6, 2017, Pages 1871-1877

  Miles, Lachlan F ^a   Coulson, Timothy G ^b   Galhardo, Carlos ^c   Falter, Florian ^b  

^a AUSTIN HEALTH   (Australia)

^b PAPWORTH HOSPITAL   (United Kingdom)

^c National Cardiology Institute   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; MANNITOL; ANTICOAGULANT AGENT;

AFRICA; ANESTHESIOLOGIST; ANTICOAGULATION; ARTICLE; ASIA; AUSTRALIA; BLOOD CLOTTING TIME; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CLINICAL PRACTICE; CRYSTALLOID; EUROPE; HEALTH CARE SURVEY; HEART SURGERY; HUMAN; MIDDLE EAST; NEW ZEALAND; NORTH AMERICA; PRIORITY JOURNAL; SOUTH AMERICA; BLOOD CLOTTING; DRUG EFFECTS; HEART ASSIST DEVICE; PHYSIOLOGY; PROCEDURES; QUESTIONNAIRE;

ANESTHESIOLOGISTS; ANTICOAGULANTS; BLOOD COAGULATION; CARDIOPULMONARY BYPASS; HEART-ASSIST DEVICES; HUMANS; SURVEYS AND QUESTIONNAIRES;

EID: 85020700157     PISSN: 00032999     EISSN: 15267598     Source Type: Journal    
DOI: 10.1213/ANE.0000000000002052     Document Type: Article

References (36)

1. Zimmer HG. The heart-lung machine was invented twice-the first time by Max von Frey. Clin Cardiol. 2003;26:443-445.
2. Dennis C, Spreng DS Jr, Nelson GE, et al. Development of a pump-oxygenator to replace the heart and lungs; an apparatus applicable to human patients, and application to one case. Ann Surg. 1951;134:709-721.
3. Gibbon JH Jr. Application of a mechanical heart and lung apparatus to cardiac surgery. Minn Med. 1954;37:171-185.
4. Itoh H, Sano S, Pouard P. Pediatric perfusion in Japan: 2010 practice survey. Perfusion. 2012;27:72-77.
5. Tuble SC, Willcox TW, Baker RA. Australian and New Zealand perfusion survey: Management and procedure. J Extra Corpor Technol. 2009;41:64-72.
6. Warren OJ, Wallace S, de Wit KL, Vincent C, Darzi AW, Athanasiou T. Variations in the application of various perfusion technologies in Great Britain and Ireland-a national survey. Artif Organs. 2010;34:200-205.
7. Charrière JM, Durand C, Mandon N, Le Guen AF, Jayle C, Debaene B. [French national survey of the use of monitoring devices during cardiopulmonary bypass in 2001] [in French]. Ann Fr Anesth Reanim. 2003;22:414-420.
8. Boldt J, Mayer J, Brosch C, Lehmann A, Mengistu A. Volume replacement with a balanced hydroxyethyl starch (HES) preparation in cardiac surgery patients. J Cardiothorac Vasc Anesth. 2010;24:399-407.
9. Boldt J, Suttner S, Brosch C, Lehmann A, Röhm K, Mengistu A. Cardiopulmonary bypass priming using a high dose of a balanced hydroxyethyl starch versus an albumin-based priming strategy. Anesth Analg. 2009;109:1752-1762.
10. Farrugia A. The Boldt affair: Correcting a collective failure. Anesth Analg. 2012;115:207.
11. Ohqvist G, Settergren G, Lundberg S. Pulmonary oxygenation, central haemodynamics and glomerular filtration following cardiopulmonary bypass with colloid or non-colloid priming solution. Scand J Thorac Cardiovasc Surg. 1981;15:257-262.
12. Ohqvist G, Settergren G, Bergström K, Lundberg S. Plasma colloid osmotic pressure during open-heart surgery using noncolloid or colloid priming solution in the extracorporeal circuit. Scand J Thorac Cardiovasc Surg. 1981;15:251-255.
13. Sanchez de Léon R, Paterson JL, Sykes MK. Changes in colloid osmotic pressure with plasma albumin concentration associated with extracorporeal circulation. Br J Anaesth. 1982;54:465-473.
14. Sade RM, Stroud MR, Crawford FA Jr, Kratz JM, Dearing JP, Bartles DM. A prospective randomized study of hydroxyethyl starch, albumin, and lactated Ringer's solution as priming fluid for cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1985;89:713-722.
15. Marelli D, Paul A, Samson R, Edgell D, Angood P, Chiu RC. Does the addition of albumin to the prime solution in cardiopulmonary bypass affect clinical outcome?. A prospective randomized study. J Thorac Cardiovasc Surg. 1989;98:751-756.
16. Himpe D. Colloids versus crystalloids as priming solutions for cardiopulmonary bypass: A meta-analysis of prospective, randomised clinical trials. Acta Anaesthesiol Belg. 2003;54:207-215.
17. Buhre W, Hoeft A, Schorn B, Weyland A, Scholz M, Sonntag H. Acute affect of mitral calve replacement on extravascular lung water in patients receiving colloid or crystalloid priming of cardiopulmonary bypass. Br J Anaesth. 1997;79:311-316.
18. Scott DA, Hore PJ, Cannata J, Masson K, Treagus B, Mullaly J. A comparison of albumin, polygeline and crystalloid priming solutions for cardiopulmonary bypass in patients having coronary artery bypass graft surgery. Perfusion. 1995;10:415-424.
19. Hoeft A, Korb H, Mehlhorn U, Stephan H, Sonntag H. Priming of cardiopulmonary bypass with human albumin or Ringer lactate: Effect on colloid osmotic pressure and extravascular lung water. Br J Anaesth. 1991;66:73-80.
20. Cochrane Injuries Group Albumin Reviewers CIGA. Human albumin administration in critically ill patients: Systematic review of randomised controlled trials. BMJ. 1998;317:235-240.
21. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R; SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med. 2004;350:2247-2256.
22. Alderson P, Bunn F, Lefebvre C, et al. Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev. 2004;4:CD001208.
23. Shafer SL. Shadow of doubt. Anesth Analg. 2011;112:498-500.
24. Liskaser F, Story DA, Hayhoe M, Poustie SJ, Bailey MJ, Bellomo R. Effect of pump prime on acidosis, strong-ion-difference and unmeasured ions during cardiopulmonary bypass. Anaesth Intensive Care. 2009;37:767-772.
25. Davies PG, Venkatesh B, Morgan TJ, et al. Plasma acetate, gluconate and interleukin-6 profiles during and after cardiopulmonary bypass: A comparison of Plasma-Lyte 148 with a bicarbonate-balanced solution. Crit Care. 2011;15:R21.
26. Boks RH, Wijers MJ, Hofland J, Takkenberg JJ, Bogers AJ. Low molecular starch versus gelatin plasma expander during CPB: Does it make a difference?. Perfusion. 2007;22:333-337.
27. Yap WW, Young D, Pathi V. Effects of gelatin and medium molecular weight starch as priming fluid in cardiopulmonary bypass-a randomised controlled trial. Perfusion. 2007;22:57-61.
28. Alavi SM, Ahmadi BB, Baharestani B, Babaei T. Comparison of the effects of gelatin, Ringer's solution and a modern hydroxyl ethyl starch solution after coronary artery bypass graft surgery. Cardiovasc J Afr. 2012;23:428-431.
29. Tiryakioǧlu O, Yildiz G, Vural H, Goncu T, Ozyazicioglu A, Yavuz S. Hydroxyethyl starch versus Ringer solution in cardiopulmonary bypass prime solutions (a randomized controlled trial). J Cardiothorac Surg. 2008;3:45.
30. Kimenai DM, Bastianen GW, Daane CR, et al. Effect of the colloids gelatin and HES 130/0.4 on blood coagulation in cardiac surgery patients: A randomized controlled trial. Perfusion. 2013;28:512-519.
31. Gurbuz HA, Durukan AB, Salman N, et al. Hydroxyethyl starch 6%, 130/0.4 vs a balanced crystalloid solution in cardiopulmonary bypass priming: A randomized, prospective study. J Cardiothorac Surg. 2013;8:71.
32. Akkucuk FG, Kanbak M, Ayhan B, Celebioglu B, Aypar U. The effect of HES (130/0.4) usage as the priming solution on renal function in children undergoing cardiac surgery. Ren Fail. 2013;35:210-215.
33. Van der Linden P, Dumoulin M, Van Lerberghe C, Torres CS, Willems A, Faraoni D. Efficacy and safety of 6% hydroxyethyl starch 130/0.4 (Voluven) for perioperative volume replacement in children undergoing cardiac surgery: A propensity-matched analysis. Crit Care. 2015;19:87.
34. Miao N, Yang J, Du Z, et al. Comparison of low molecular weight hydroxyethyl starch and human albumin as priming solutions in children undergoing cardiac surgery. Perfusion. 2014;29:462-468.
35. Lilley A. The selection of priming fluids for cardiopulmonary bypass in the UK and Ireland. Perfusion. 2002;17:315-319.
36. Lobato RL, Despotis GJ, Levy JH, et al. Anticoagulation management during cardiopulmonary bypass: A survey of 54 North American institutions. J Thorac Cardiovasc Surg. 2010;139:1665-1666.